nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—MTOR—leg—osteoarthritis	0.0882	0.227	CbGeAlD
Tacrolimus—MTOR—forelimb—osteoarthritis	0.0875	0.225	CbGeAlD
Tacrolimus—MTOR—hindlimb—osteoarthritis	0.0788	0.203	CbGeAlD
Tacrolimus—ORM1—vertebral column—osteoarthritis	0.0645	0.166	CbGeAlD
Tacrolimus—ABCA5—tendon—osteoarthritis	0.0266	0.0683	CbGeAlD
Tacrolimus—PPP3CA—tendon—osteoarthritis	0.0179	0.0462	CbGeAlD
Tacrolimus—MTOR—tendon—osteoarthritis	0.0133	0.0341	CbGeAlD
Tacrolimus—FKBP1A—tendon—osteoarthritis	0.0119	0.0307	CbGeAlD
Tacrolimus—PPP3CA—Innate Immune System—CTSK—osteoarthritis	0.00281	0.0046	CbGpPWpGaD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.00277	0.00453	CbGpPWpGaD
Tacrolimus—MTOR—TSLP Signaling Pathway—CXCL8—osteoarthritis	0.00276	0.00452	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—MMP9—osteoarthritis	0.00274	0.00449	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—ESR1—osteoarthritis	0.00273	0.00447	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL1A—osteoarthritis	0.00267	0.00437	CbGpPWpGaD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—osteoarthritis	0.00266	0.00436	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IHH—osteoarthritis	0.00263	0.00431	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—osteoarthritis	0.00256	0.00418	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—PTGS2—osteoarthritis	0.00243	0.00397	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—CXCL8—osteoarthritis	0.00235	0.00385	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—HSPA5—osteoarthritis	0.00233	0.00381	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.0023	0.00376	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CAMK2B—osteoarthritis	0.00229	0.00375	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—FMOD—osteoarthritis	0.00229	0.00375	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—TGFB1—osteoarthritis	0.00226	0.0037	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL1B—osteoarthritis	0.00226	0.00369	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.00222	0.00363	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—TIMP1—osteoarthritis	0.00222	0.00363	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—IL1B—osteoarthritis	0.00219	0.00359	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—IL1B—osteoarthritis	0.00218	0.00357	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoarthritis	0.00216	0.00353	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—MMP9—osteoarthritis	0.00213	0.00348	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.00211	0.00346	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—TNF—osteoarthritis	0.00211	0.00346	CbGpPWpGaD
Tacrolimus—CYP3A5—Biological oxidations—GSTO1—osteoarthritis	0.00207	0.00338	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—IGF1—osteoarthritis	0.00206	0.00337	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—FN1—osteoarthritis	0.00206	0.00337	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IHH—osteoarthritis	0.00204	0.00334	CbGpPWpGaD
Tacrolimus—CYP3A5—Metapathway biotransformation—GSTO1—osteoarthritis	0.00204	0.00334	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—IGF1—osteoarthritis	0.00201	0.00328	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00199	0.00326	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFBI—osteoarthritis	0.00196	0.00321	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—CRP—osteoarthritis	0.00196	0.0032	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IHH—osteoarthritis	0.00184	0.00302	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MCF2L—osteoarthritis	0.00184	0.00302	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—IL1B—osteoarthritis	0.00182	0.00298	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.00182	0.00297	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.00181	0.00296	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TGFB1—osteoarthritis	0.00175	0.00287	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.00171	0.00279	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—IL6—osteoarthritis	0.0017	0.00279	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—GSTO1—osteoarthritis	0.0017	0.00278	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.0017	0.00278	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00169	0.00276	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00165	0.0027	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—BGN—osteoarthritis	0.00164	0.00269	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CAMK2B—osteoarthritis	0.00164	0.00268	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CTSK—osteoarthritis	0.00164	0.00268	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TNF—osteoarthritis	0.00164	0.00268	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.0016	0.00261	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TNF—osteoarthritis	0.00159	0.0026	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—CRP—osteoarthritis	0.00159	0.0026	CbGpPWpGaD
Tacrolimus—MTOR—CXCR4-mediated signaling events—MMP9—osteoarthritis	0.00157	0.00257	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00156	0.00255	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—ESR1—osteoarthritis	0.00155	0.00254	CbGpPWpGaD
Tacrolimus—MTOR—TSLP Signaling Pathway—IL6—osteoarthritis	0.00155	0.00254	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—TGFB1—osteoarthritis	0.00153	0.00251	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFBI—osteoarthritis	0.00152	0.00249	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00145	0.00238	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.00144	0.00236	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IHH—osteoarthritis	0.00143	0.00234	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MCF2L—osteoarthritis	0.00143	0.00234	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00139	0.00228	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.00136	0.00223	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—COL9A2—osteoarthritis	0.00135	0.00221	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL6—osteoarthritis	0.00132	0.00216	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—GSTO1—osteoarthritis	0.00132	0.00215	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—COL9A1—osteoarthritis	0.00131	0.00215	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CRP—osteoarthritis	0.00131	0.00214	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HSPA5—osteoarthritis	0.0013	0.00213	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.00129	0.00212	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FMOD—osteoarthritis	0.00129	0.00211	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL1A—osteoarthritis	0.00128	0.00209	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—BGN—osteoarthritis	0.00127	0.00209	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1RN—osteoarthritis	0.00127	0.00208	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—CRP—osteoarthritis	0.00126	0.00207	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—FN1—osteoarthritis	0.00126	0.00206	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.00123	0.00202	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CTSK—osteoarthritis	0.00123	0.00201	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL1B—osteoarthritis	0.00122	0.002	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.00121	0.00198	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	0.0012	0.00196	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00119	0.00195	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CTSK—osteoarthritis	0.00118	0.00193	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IHH—osteoarthritis	0.00115	0.00188	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00111	0.00182	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—IGF1—osteoarthritis	0.0011	0.0018	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.00108	0.00177	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—MMP3—osteoarthritis	0.00106	0.00173	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.00105	0.00172	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—COL9A2—osteoarthritis	0.00105	0.00172	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00104	0.0017	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.00103	0.00169	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—COL9A1—osteoarthritis	0.00102	0.00167	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL1B—osteoarthritis	0.000993	0.00162	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000985	0.00161	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000971	0.00159	CbGpPWpGaD
Tacrolimus—MTOR—IRS-mediated signalling—IL6—osteoarthritis	0.000966	0.00158	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.000962	0.00157	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.000948	0.00155	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events—IL6—osteoarthritis	0.00094	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HSPA5—osteoarthritis	0.000937	0.00153	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.000932	0.00152	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1A—osteoarthritis	0.000913	0.00149	CbGpPWpGaD
Tacrolimus—MTOR—Insulin receptor signalling cascade—IL6—osteoarthritis	0.000907	0.00148	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—IL6—osteoarthritis	0.000907	0.00148	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—BMP2—osteoarthritis	0.000901	0.00147	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	0.000885	0.00145	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFBI—osteoarthritis	0.000856	0.0014	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—FMOD—osteoarthritis	0.000852	0.00139	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000848	0.00139	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.000816	0.00134	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—SMAD3—osteoarthritis	0.000807	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MCF2L—osteoarthritis	0.000804	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IHH—osteoarthritis	0.000804	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.000804	0.00132	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000789	0.00129	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.000785	0.00128	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CRP—osteoarthritis	0.000763	0.00125	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—IL6—osteoarthritis	0.000759	0.00124	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—IL6—osteoarthritis	0.000754	0.00123	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.000753	0.00123	CbGpPWpGaD
Tacrolimus—MTOR—Disease—GSTO1—osteoarthritis	0.00074	0.00121	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TNF—osteoarthritis	0.00072	0.00118	CbGpPWpGaD
Tacrolimus—MTOR—Disease—BGN—osteoarthritis	0.000717	0.00117	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CTSK—osteoarthritis	0.000715	0.00117	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CAMK2B—osteoarthritis	0.000715	0.00117	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000715	0.00117	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—BMP2—osteoarthritis	0.000699	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CXCL8—osteoarthritis	0.000695	0.00114	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGES—osteoarthritis	0.000694	0.00114	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—TGFB1—osteoarthritis	0.000661	0.00108	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—IL6—osteoarthritis	0.000645	0.00105	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	0.00063	0.00103	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—SMAD3—osteoarthritis	0.000626	0.00102	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP3—osteoarthritis	0.000624	0.00102	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000617	0.00101	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—FMOD—osteoarthritis	0.000616	0.00101	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—osteoarthritis	0.000607	0.000993	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—COL9A2—osteoarthritis	0.00059	0.000966	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000585	0.000958	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL6—osteoarthritis	0.000581	0.000951	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—osteoarthritis	0.00058	0.000948	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—osteoarthritis	0.000577	0.000944	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—osteoarthritis	0.000574	0.000939	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—COL9A1—osteoarthritis	0.000573	0.000938	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	0.000572	0.000936	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CRP—osteoarthritis	0.000572	0.000935	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—osteoarthritis	0.000571	0.000934	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HSPA5—osteoarthritis	0.000569	0.00093	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SMAD3—osteoarthritis	0.000565	0.000924	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.000559	0.000914	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000557	0.000911	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1RN—osteoarthritis	0.000553	0.000905	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.000547	0.000894	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CXCL8—osteoarthritis	0.000543	0.000889	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—osteoarthritis	0.000537	0.000879	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—osteoarthritis	0.000537	0.000879	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000537	0.000879	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HSPA5—osteoarthritis	0.000533	0.000872	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—osteoarthritis	0.000533	0.000871	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—FMOD—osteoarthritis	0.00053	0.000868	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000528	0.000864	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—osteoarthritis	0.000526	0.00086	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TIMP1—osteoarthritis	0.000507	0.00083	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGES—osteoarthritis	0.000502	0.000821	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000489	0.000801	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTO1—osteoarthritis	0.000489	0.0008	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP3—osteoarthritis	0.000484	0.000792	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—LEP—osteoarthritis	0.000483	0.00079	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000482	0.000788	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—osteoarthritis	0.000479	0.000783	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—osteoarthritis	0.000476	0.000779	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000476	0.000779	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—BGN—osteoarthritis	0.000474	0.000775	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTGS2—osteoarthritis	0.000473	0.000773	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—FMOD—osteoarthritis	0.000465	0.00076	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	0.000462	0.000755	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ESR1—osteoarthritis	0.000461	0.000754	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FN1—osteoarthritis	0.000456	0.000745	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SMAD3—osteoarthritis	0.000438	0.000717	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGES—osteoarthritis	0.000432	0.000707	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.0004	0.000654	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IGF1—osteoarthritis	0.000399	0.000653	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1A—osteoarthritis	0.000398	0.000652	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—BMP2—osteoarthritis	0.000393	0.000643	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—osteoarthritis	0.00039	0.000638	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGES—osteoarthritis	0.000379	0.00062	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LEP—osteoarthritis	0.000375	0.000613	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTGS2—osteoarthritis	0.000366	0.000599	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—osteoarthritis	0.000366	0.000599	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ESR1—osteoarthritis	0.000358	0.000585	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTO1—osteoarthritis	0.000354	0.000579	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FN1—osteoarthritis	0.000353	0.000578	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SMAD3—osteoarthritis	0.000352	0.000576	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—BGN—osteoarthritis	0.000343	0.00056	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—osteoarthritis	0.000342	0.000559	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—osteoarthritis	0.000333	0.000545	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL8—osteoarthritis	0.000321	0.000525	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MMP1—osteoarthritis	0.000315	0.000516	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF1—osteoarthritis	0.000309	0.000506	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—osteoarthritis	0.000305	0.000499	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTO1—osteoarthritis	0.000305	0.000498	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—BGN—osteoarthritis	0.000295	0.000483	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000293	0.00048	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—osteoarthritis	0.00029	0.000475	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000289	0.000473	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—FN1—osteoarthritis	0.000288	0.000471	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000286	0.000468	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—osteoarthritis	0.000279	0.000456	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP3—osteoarthritis	0.000272	0.000445	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00027	0.000441	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTO1—osteoarthritis	0.000267	0.000437	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—osteoarthritis	0.000265	0.000433	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—BGN—osteoarthritis	0.000258	0.000423	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—osteoarthritis	0.000257	0.000421	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF1—osteoarthritis	0.000252	0.000413	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL8—osteoarthritis	0.000249	0.000407	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SMAD3—osteoarthritis	0.000246	0.000403	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—osteoarthritis	0.000239	0.000391	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000233	0.000382	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—osteoarthritis	0.000225	0.000368	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LEP—osteoarthritis	0.000211	0.000345	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—osteoarthritis	0.000209	0.000342	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—osteoarthritis	0.000208	0.00034	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—osteoarthritis	0.000206	0.000337	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ESR1—osteoarthritis	0.000201	0.000329	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—osteoarthritis	0.0002	0.000327	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FN1—osteoarthritis	0.000199	0.000325	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00019	0.000312	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—osteoarthritis	0.000186	0.000304	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—osteoarthritis	0.00018	0.000295	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—osteoarthritis	0.000174	0.000285	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000164	0.000269	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—BGN—osteoarthritis	0.000159	0.000261	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—osteoarthritis	0.000151	0.000247	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—osteoarthritis	0.000149	0.000244	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—osteoarthritis	0.00014	0.000229	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—osteoarthritis	0.00014	0.000229	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—osteoarthritis	0.000136	0.000223	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—osteoarthritis	0.000127	0.000207	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—osteoarthritis	0.000122	0.000199	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—osteoarthritis	0.000112	0.000184	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—osteoarthritis	0.000104	0.000171	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—osteoarthritis	9.85e-05	0.000161	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—osteoarthritis	8.48e-05	0.000139	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—osteoarthritis	7.86e-05	0.000129	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—osteoarthritis	7.43e-05	0.000122	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—osteoarthritis	4.58e-05	7.49e-05	CbGpPWpGaD
